Professional Documents
Culture Documents
net/publication/320830089
CITATIONS READS
0 129
4 authors, including:
All content following this page was uploaded by Syed Shahmeer Raza on 03 November 2017.
ABSTRACT
INTRODUCTION: Glomus tympanicum tumor is a benign but most common tumour of the middle ear with relatively
good prognosis if detected early. These tumours arise from paraganglionic tissue and are innervated by parasympathet-
ic autonomic nervous system (PANS). They are more common in females. The spread of these tumours is multidirectional
and simultaneous. They may be asymptomatic or present with pulsatile tinnitus. On examination, the eardrum shows a
rising sun or setting sun appearance. On CT scan, we can see a soft tissue mass lateral to the cochlear promontory which
may fill the middle ear cavity. Surgical resection is the treatment of choice.
We present a case of 40 years old anemic female who presented to us with a history of constant pain, progressive left
ear hearing loss and a mass in left ear for the last 3 months. On CT, we saw a soft tissue density lesion enhancing the
middle ear and protruding into the external ear.
KEY WORDS: Glomus tumor, Glomus tympanicum tumor, Glomus jugulare tumor
This article may be cited as: Raza SS, Hussain AK, Saboor H, Qureshi MSH. Glomus Tympanicum Tumor – A
rare presentation in a tertiary care hospital of Peshawar. NJMS. 2016; 1(3):138-40
INTRODUCTION
proper differentiation between Fisch type A and Fisch type
Glomus tympanicum tumour is a very rare, benign, lo- B. The two tumors are differentiated from each other by
cally invasive and slow growing tumor of middle ear. It is determining status of bone erosion on the jugular bulb.
the most common primary neoplasm of the middle ear and Fisch type B tumor is characterized by extensive erosion.
the second most common tumor of the temporal bone.1 For that purpose imaging of temporal bone carries a huge
Glomus tympanicum is one of the two types of Glomus significance. A combination of magnetic resonance imag-
tumors. Glomus tumors originates from glomus bodies.2 ing along with computed tomography is performed for the
Glomus bodies are normal constituent of neuro-endocrine correct diagnosis. In order to evaluate the precise size of
system.3 Glomus tympanicum is the glomus body of mid- tumor along with the feeding vessels, carotid aeteriogra-
dle ear. It also acts as a chemoreceptor and helps in the phy is performed. This imaging technique is also helpful for
maintenance of optimum middle ear pressure.4 pre-operative embolisation. However embolisation of glo-
The glomus tumors can classified into Fisch type A and mus tympanicum tumors is not necessary.7 Though most
Fisch type B.5 The former is also known as glomus tym- temporal bone paragangliomas are diagnosed clinically
panicum tumour and latter is also known as glomus jug- and radiologically8, they are confirmed histopathologically
ulare tumor. Glomus tympanicum tumors originates from by the presence of monomorphic cell nests, vascularized
Jacobson’s nerve while on the other hand glomus jugulare stroma and S-100 protein immuno-stains for chromogr-
tumors arise from jugular vein that is present in the jugular anin, synaptophysin and sustentacular cells.
fossa.6 Glomus jugulo-tympanicum refers to an extra-ordi- The presenting features, usually in middle-aged women
nary large tumor that cannot be distinguished or it also re- include pulsatile tinnitus, recurrent ear bleeding, deafness,
fers to the glomus jugulare tumor when it reaches the mid- otalgia, dizziness and facial and lower cranial nerve palsies.
dle ear. Due to the difference in surgical management of 9
Glomus tumors can be treated with radiotherapy or sur-
each type of glomus tumor it is highly significant to make a gery. However, the standard treatment is surgical excision
which often requires sophisticated and extensive proce-
1-3
Khyber Medical College, Peshawar Pakistan. dures and can also result in severe peri-operative hemor-
4
Institute of Public Health and Social Sciences, Khyber Medical rahage.10
University, Peshawar Pakistan.
138
NJMS Vol. 1 No. 3 July – September 2016
GLOMUS TYMPANICUM TUMOR – A RARE PRESENTATION IN A TERTIARY CARE HOSPITAL OF PESHAWAR
Peshawar with a history of post operative bleeding after an es and included sections of brain appeared normal.
attempt to excise a mass in her left ear at some peripher- FIG (A)(B)(C): In this axial CT scan of the brain of the
al hospital in countryside. She gave a history of constant patient, soft tissue density lesion enhancing the middle ear
pain and mass in the left ear for 3 months duration and and protruding into the external ear. Mass eroding middle
progressive left-sided hearing loss with it. According to her ear ossicles and basal turn of cochlea. There was no ero-
the pain relieved after taking pain killers. There was no his- sion of scutum and fluid was seen in left mastoid air cells.
tory of vertigo, diabetes mellitus, hypertension or ischemic Para nasal sinuses and included sections of brain appeared
heart disease. There was also no evidence of seventh or normal.
other cranial nerve deficit or vestibular finding. These findings were suggestive of the possibilities of
On examination the patient was anemic but not jaun- cholesteatoma or glomus tumor. A diagnosis of glomus
diced, no abnormalities detected in her systemic exam- tympanicum tumor was established and modified radical
ination. Tuning fork tests showed Rinne’s negative in left mastoidectomy was done in the left ear and all the middle
ear and Weber’s test showed lateralization to the left ear. ear cleft was examined which was occupied by the mass.
A Computed Tomography (CT) of the temporal bones re- Clearance of the mass was done but its clearance from hy-
vealed soft tissue density enhancing middle ear protruding potympanicum was doubtful because of profuse bleeding.
into external ear. The mass was eroding middle ear ossicles The patient was kept under observation in the otolaryngol-
and basal turn of cochlea. There was no erosion of scutum ogy ward for couple of days and was then subsequently
and fluid was seen in left mastoid air cells. Para nasal sinus- discharged.
139
NJMS Vol. 1 No. 3 July – September 2016
GLOMUS TYMPANICUM TUMOR – A RARE PRESENTATION IN A TERTIARY CARE HOSPITAL OF PESHAWAR
ing pharyngeal artery. Scintigraphy demonstrates high up- 6. Wang BY ZD, Nonaka D. . Tumors of the nervous system. In: L IB,
take.13 14 editor. Surgical Pathology of the Head and Neck. Third Edition
Surgical resection is the treatment of choice.15 The 2008 ed: CRC Press:pp. 669-771.
size and the extent of the glomus tumour determine the 7. Durvasula VS, De R, Baguley DM, Moffat DA. Laser excision of glo-
surgical procedure needed.16 Type 1 glomus tympanicum mus tympanicum tumours: long-term results. European Archives
tumours are generally approached by trascanal tympanot- of Oto-Rhino-Laryngology and Head & Neck 2005;262(4):325-27.
omy while Type 3 tumours require mastoidectomy with 8. Taziki MH, Behnampour N. A study of the etiology of referred
extended facial recess approach. However, Type 4 glomus Otalgia. Iranian journal of otorhinolaryngology 2012;24(69):171-
tumours need intracranial surgical excision of the tumour.17 76.
9. Gilbo P, Morris CG, Amdur RJ, Werning JW, Dziegielewski PT, Kir-
ACKNOWLEDGEMENT wan J, et al. Radiotherapy for benign head and neck paraganglio-
We acknowledge the study participants who took time out for this mas: A 45‐year experience. Cancer 2014;120(23):3738-43.
study and shared their experience and views. 10. Robinson PJ, Grant HR, Bown SG. NdYAG laser treatment of a glo-
mus tympanicum tumour. The Journal of Laryngology & Otology
NOTES ON CONTRIBUTORS 1993;107(03):236-37.
The study was part of SSR, AKH, HS & MSHQ all authors were 11. Manolidis S, Shohet JA, Jackson CG, Glasscock ME. Malignant glo-
involved in every part of Manuscript writing, analysis, Protocol mus tumors. The Laryngoscope 1999;109(1):30-34.
developments, and data collection process. 12. Lemmerling M DFB, editors. Temporal bone imaging: Springer,
2014.
CONFLICT OF INTEREST 13. Whiteman M, Serafini AN, Telischi FF, Civantos FJ, Falcone S. 111In
Authors declare no conflict of interest. octreotide scintigraphy in the evaluation of head and neck le-
sions. American Journal of Neuroradiology 1997;18(6):1073-80.
14. Intenzo CM, Jabbour S, Lin HC, Miller JL, Kim SM, Capuzzi DM,
REFERENCES et al. Scintigraphic Imaging of Body Neuroendocrine Tumors 1.
Radiographics 2007;27(5):1355-69.
1. O’Leary MJ, Shelton C, Giddings NA, Kwartler J, Brackmann DE. 15. Lemmerling M, De Foer B. Imaging of cholesteatomatous and
Glomus tympanicum tumors: a clinical perspective. The Laryngo- non-cholesteatomatous middle ear disease. Radiology of the pe-
scope 1991;101(10):1038-43. trous bone: Springer, 2004:31-47.
2. Merchant SN, Nadol JB. Schuknecht’s Pathology of the Ear: 16. Sen C, Hague K, Kacchara R, Jenkins A, Das S, Catalano P. Jugu-
PMPH-USA, 2010. lar foramen: microscopic anatomic features and implications for
3. Rigby PL, Jackler RK. Clinicopathologic presentation and diagnos- neural preservation with reference to glomus tumors involving
tic imaging of jugular foramen tumors. Operative Techniques in the temporal bone. Neurosurgery 2001;48(4):838-48.
Otolaryngology-Head and Neck Surgery 1996;7(2):99-105. 17. Artico M, De Vincentiis M, Ionta B, Bianchi E, Bosco S, Montele-
4. Rockley T, Hawke M. The glomus tympanicum: a middle ear che- one M, et al. Immunohistochemical profile of neurotrophins and
moreceptor? The Journal of otolaryngology 1989;18(7):370-73. MIB-1 in jugulotympanic paragangliomas: prognostic value and
5. Oldring D, Fisch U. Glomus tumors of the temporal region: surgi- review of the literature. International journal of immunopatholo-
cal therapy. Otology & Neurotology 1979;1(1):7-18. gy and pharmacology 2012;25(1):183-91.
140
NJMS Vol. 1 No. 3 July – September 2016